GAGNON SUZANNE purchased 714.2% of their position (7.14K shares) of PANBELA THERAPEUTICS, INC. on the open market
Open‑market purchases signal personal conviction — classified as a major conviction buy.
P · 1 purchase
Filed: 9/24/2019ACC: 0001437749-19-018985
+14.28K
Net shares
Net buyer
$0.00
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
14.28K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+7.14K
Price / share
—
Trade value
—
% of position
714.2%
9/20/2019
1K→8.14K
Total
Net shares
+7.14K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/20/2019 | P · Purchase | +7.14K | — | — | 714.2% | 1K | 8.14K |
| Total | +7.14K | $0.00 | ||||||
Derivative Transactions1
Warrants (right to buy)
Indirect
Converts to
Common Stock
7.14K shares
Shares
+7.14K
Strike price
4
Held after
7.14K
Exercisable
—
9/20/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants (right to buy) Indirect | Common Stock7.14K shares | 9/20/2019 | P · Purchase | +7.14K | 4 | — | 7.14K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned43K
Total
43K direct43K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 43K | Direct |
| Total | 43K | 43K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported